From: Procalcitonin for infections in the first week after pediatric liver transplantation
No Infection N = 24 (%) | Infection N = 17 (%) | P value | |
---|---|---|---|
DIAGNOSIS | |||
Biliary atresia | 12 (50) | 6 (35.3) | 0.35 |
Other cholestatic | 1 (4.2) | 1 (5.9) | 1 |
ALF | 3 (12.5) | 1 (5.9) | 0.60 |
Metabolic | 3 (12.5) | 1 (5.9) | 0.60 |
Immunologic | 1 (4.2) | 2 (11.8) | 0.56 |
Tumor | 3 (12.5) | 1 (5.9) | 0.60 |
Other | 1 (4.2) | 5 (29.4) | 0.06 |
Male | 15 (62.5) | 9 (52.9) | 0.50 |
Female | 9 (37.5) | 8 (47.1) | 0.50 |
Age at pLT (months) | 26 (IQR 9-131) | 45 (IQR 13-149) | 0.80 |
Weight (kgs) | 13.3 (IQR 7.6-38) | 17 (IQR 8.5-40) | 0.80 |
SURGICAL | |||
Whole | 10 (41.7) | 10 (58.8) | 0.27 |
Technical variant | 14 (58.3) | 7 (41.2) | 0.27 |
Total ischemia time (min) | 378 (CI 346-409) | 416 (CI 355-476) | 0.30 |
Warm ischemia time (min) | 61 (CI 51-70) | 54 (CI 43-63) | 0.24 |
Peak PCT (ng/ml) | 7.63 (IQR 3.6-10.3) | 5.6 (IQR 3.9-10.8) | 0.60 |